ClinicalTrials.Veeva

Menu

Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Multiple Sclerosis
Restless Legs Syndrome

Treatments

Behavioral: Behavioral Intervention (BIPAMS)

Study type

Interventional

Funder types

Other

Identifiers

NCT04061681
IRB-300003877

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of a 16-week behavioral intervention for increasing physical activity and reducing restless legs syndrome (RLS) severity in persons with multiple sclerosis (MS) and RLS. The study includes a proposed sample of 20 persons with MS and RLS that will be randomized into either a 16-week behavioral intervention arm aimed at increasing physical activity or a 16-week wait-list control arm.

Full description

The primary aim of the proposed pilot RCT involves examining the efficacy of a 16-week behavioral intervention for increasing physical activity and reducing RLS severity in persons with MS and RLS. Secondarily, the investigators will be assessing changes in sleep quality and daytime sleepiness following the behavioral intervention. The study includes a proposed sample of 20 persons with MS and RLS that will complete a baseline testing session for measures of physical activity, restless legs syndrome severity, sleep quality, and daytime sleepiness. Participants will then be randomized into one of two study arms: (1) a 16-week Social Cognitive Theory-based behavioral intervention aimed at increasing physical activity; or (2) 16-week waitlist control with the option of completing the intervention upon completion of the study. All participants will complete a follow-up testing session at the conclusion of each 16-week arm.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of multiple sclerosis
  • Relapse free in the past 30 days
  • Positive screen for restless legs syndrome
  • Non-active (not engaging in 30 minutes of activity per day on more than 2 days per week in the previous six months)
  • Ambulatory without assistance
  • Internet and email access

Exclusion criteria

  • Diagnosis of radiculopathy, peripheral edema, peripheral neuropathy, iron deficiency (i.e., anemia) renal disease, or diabetes
  • Screen at moderate or high risk for undertaking strenuous or maximal exercise

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

15 participants in 2 patient groups

Behavioral Intervention (BIPAMS)
Experimental group
Description:
Participants will complete a 16-week behavioral intervention to increase physical activity levels.
Treatment:
Behavioral: Behavioral Intervention (BIPAMS)
Waitlist Control
No Intervention group
Description:
Participants will have 16-weeks of no intervention or interaction.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems